Exact Sciences to participate in Cowen Liquid Biopsy Summit
MADISON, Wis., Sept. 17, 2020 /PRNewswire/ — Exact Sciences Corp. (NASDAQ:EXAS) today announced that company management will participate in the following event and invited investors to participate by webcast.
- Cowen Liquid Biopsy Summit
Presentation on Thursday, September 24, 2020, at 10:30 a.m. EDT
The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard and Oncotype DX, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company’s website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended …